Health Trials

Refractory Thyroid Cancer

1

Review clinical trials related to Refractory Thyroid Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer

The purpose of this study to learn more about the use of redifferentiating medications as a standard treatment for radioactive iodine/RAI-refractory thyroid cancer. This study is a registry study.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Apr 27, 2026Locations: 1Duration: 100 Years
Eligibility criteria

Patients ≥ 18 years old at time of consent [+4]

RAI refractory thyroid cancer patients that will receive redifferentiation agent...

Read more